NASH-linked gene discovery could inspire new drugs to treat liver damage

A TGen-led research team found that increased activity of the gene AEBP1 drives severe liver fibrosis in patients with nonalcoholic steatohepatitis (NASH). They believe the finding will inspire new treatments to prevent liver damage in those patients.